TOPIC 32 – Congenital heart defects  by unknown
Archives of Cardiovascular Diseases Supplements (2013), 5, 79-80 79
© Elsevier Masson SAS. All rights reserved.
Conclusion: Clinical presentation and outcome of Ebstein’s anomaly varies 
considerably by anatomic severity and many cases are discovered in adults. The 
prognosis is worsening by arrhythmia and heart failure. Optimal timing of intervention 
is often diffi cult and must be individualized. Conservative surgery and anti arrhythmic 
therapy had enhanced the prognosis of this congenital heart malformation.
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ALCAPA syndrome is a rare congenital heart disease that is mainly diagnosed 
during the fi rst months of life with a high early mortality in symptomatic children in 
the absence of surgery. Adult form is extremely rare and no recommendation for the 
management of this form is available. We undertook this study in order to analyze 
initial symptoms and the management of adult pts with ALCAPA.
Methods: We analyzed retrospectively the data of 9 adults (49±16 years, 3M) from 
the charts of Cardiology Departments of 5 French hospitals (Argenteuil, Bordeaux, 
Brest, Lille, Nantes and Rennes).
Results: Symptoms consisted of chest pain (44.4%), supra-ventricular arrhythmia 
(33%) and heart failure (25%). ECG showed negative T waves or ST segment depression 
in antero-septal leads in 43% of pts. Echocardiogram showed a mean LVEF of 
46±12.6% with kinetic abnormalities in 57% of the pts. Mitral regurgitation was present 
in all pts but was mainly moderate (71%). Coronary angiography was performed 
in 85.7% of pts and showed ALCAPA in all cases. CT-scan, MRI and myocardial 
scintigraphy were performed for diagnosis respectively in 57, 43 and 55.5% of the 
cases but more often for follow-up (FU). Reconstructive surgery was performed in 
8 pts and a mitral valve reconstruction in one pt. Another pt underwent 4 CABG 
several years later. Immediate post-operative complications were: cardiogenic shock 
(2 pts), non-signifi cant narrowing of the transferred coronary artery ostium that was 
treated medically (1 pt). One 70 year-old pt refused surgery. He died 2 years later. 
Medical treatment was used in 77.8% of pts: ACEI (22.2%), beta-blockers (44.4%) or 
anti-platelet agent (11.1%). A prophylactic ICD was implanted in one pt. All operated 
pts are alive with a FU of 26±24 years.
Conclusion: Diagnosis of ALCAPA in adult pts is very rare and is done mainly 
by coronary angiography in the presence of chest pain or heart failure. The results of 
surgery in addition to medical treatment are excellent.
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Introduction: A ventricular septal defect (VS D) is part of most congenital 
heart defects (CHD). 
Objective: To determine the distribution of the anatomic types of VS D in CHD.
Methods: We analysed 1178 heart specimens with CHD, focusing on the 
localization of the VS D: muscular, membranous, outlet between the two limbs of 
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The ventricular conduction system (VCS) is responsible for the rapid propagation 
of electrical activity in the ventricles. The VCS is composed of the His bundle, the 
right (RBB) and left (LBB) bundle branches and the peripheral Purkinje fi bers (PF). 
TBX1 is a major candidate gene for DiGeorge syndrome, characterized by craniofacial 
defects and cardiac malformations including tetralogy of Fallot. Multiple defects found 
in the human syndrome can be observed in Tbx1 null mouse embryos. Among these, 
Tbx1 mutant embryos display a common arterial trunk and a ventricular septal defect 
(VS D). In order to analyze the development of the VCS in Tbx1 null hearts, we have 
crossed Tbx1±with the Cx40-GFP mice to easily identify conductive myocytes. At 
E18.5, Tbx1 null hearts present a non-compact His bundle and a disconnection of the 
RBB with the PF network abnormally localized at the base of the right septal papillary 
muscle up to the VS D. Moreover, the right septal papillary muscle is enlarged and 
malformed. Using 3D reconstruction of isolated septa, we have clearly demonstrated 
the absence of the proximal RBB in Tbx1 mutant hearts, and the presence of a 
hypoplastic His bundle positioned more anteriorly in comparison to control hearts. 
Electrical activation maps of Tbx1 mutant hearts reveal an exclusively left ventricular 
activation while two breakthroughs in the right and left ventricles are observed in 
control hearts. This study revealed that the Tbx1 mutants display a RBB block. We 
carried out a detailed morphological and functional characterization of the His bundle 
and RBB at earlier stages. At E14.5, the His bundle is positioned more anteriorly in 
Tbx1-/- hearts compared to controls. No signifi cant differences were observed by 
optical mapping in Tbx1 mutant hearts. To conclude, our data strongly suggest that a 
defect in cardiac morphogenesis may be at the origin of conduction defect. 
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Ebstein’s disease in adulthood
Saoussen Antit, Sana Fennira, Mourad Mejri, Ihsen Zairi, Sofi en Kamoun, 
Sondos Kraiem
Hopital Habib Thameur, Tunis, Tunisie
Background: Ebstein’s disease is a rare congenital heart malformation, occurs 
in approximately 1 to 5 per 200,000 live births, with various clinical presentations 
depending on the age at diagnosis and the severity of the anatomical pattern.
Objective: The aim of this study is to determinate the clinical presentation, 
the echocardiographic patterns and the outcome of this malformation in adulthood.
Methods and Results: Retrospective study about 10 cases of Ebstein’s anomaly 
in adult patients (5 women and 5 men); the mean age was 32±13.9 years old [16; 
61]. The clinical manifestations were absent in 3 patients, arrhythmic manifestations 
(palpitations, lipothymia, syncope) were noted in 5 patients and congestive heart 
failure was observed in 2 patients. Electrocardiogram revealed Wolf-Parkinson-White 
syndrome in 3 cases, conduction abnormalities in 5 cases and ventricular excitability in 
2 cases. Transthoracic echocardiography confi rmed the diagnosis of Ebstein anomaly 
in all cases, showing apical displacement of the septal leafl et of the tricuspid valve. 
Three patients had the A grade of the Carpentier’s classifi cation and the others had 
the grade B. Only one patient underwent a surgical repair because a refractory heart 
failure. Anti arrhythmic and hemodynamic therapy was administrated in 6 and 4 
patients respectively. After an outcome of 6.5 years, arrhythmic and hemodynamic 
complications occurred in 3 patients and no death.
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Background: Patent ductus arteriosus is responsible for left ventricular diastolic 
and rignt ventricular systolic overload. Little is known about hemodynamic changes 
after percutaneous and surgical closure.
Methods: We conducted a bicentric prospective study of children with patent ductus 
arteriosus, evaluating the evolution of systolic and diastolic ventricular functions before, 
1 day and 1 month after successful closure, by means of transthoracic echocardiography.
Results: 33 children, age 3 months to 14.5 years, received successful closure of their 
patent ductus arteriosus, 32 percutaneously and 1 surgically. All patent ductus arteriosus 
were closed for hemodynamic reasons, with a mean diameter of 3.6±0.9 mm. There 
was a signifi cant increase in systolic (100.6±15.1 versus 95.4±15.3 mmHg, p<0.05) and 
diastolic (53.2±17.1 versus 47.8±17.2 mmHg, p<0.05) blood pressures, immediately 
after the suppression of the shunt. Left ventricular fractional shortening and end diastolic 
volumes index were signifi cantly tlower the day after closure (respectively 34.7±5.5 
versus 37.8±4.7% and 47±16.2 versus 54.6±20.1 mL/m2) and remained low compared to 
the preclosure state at follow-up (respectively 33.8±5.4 versus 37.8±4.7% and 47±12.7 
versus 54.6±20.1 mL/m2). A non signifi cant decrease in left ventricular fi lling pressures 
was observed. Right ventricular systolic parameters (TAPSE) were signifi cantly lower 
1 month after closure (19.3±2.9 versus 21.4±4.4 mm, p<0.05).
Conclusion: Changes in left ventricular volumes and function and in right 
ventricular function occur immediately after patent ductus arteriosus closure, and 
remain at 1 month of follow-up. Further studies are warranted to increase the number 
of patients and the duration of follow-up.
149
Fetal tachycardia: outcomes over twenty years in fi ve institutions in northern 
France
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CHRU Lille, cardiologie, Lille, France
Background: Fetal tachycardia is a rare disease that may result in serious 
morbidity and intra-uterine mortality. 
Aims: The purpose of our study was to review the natural history of patients 
with fetal tachycardia, to determine the incidence of post-natal arrhythmia and to 
understand the gravity of hydrops in this population.
Methods and Results: We reviewed 34 gravidas admitted for fetal tachycardia 
between 1992 and 2012, in 5 centers in northern France Twenty-four had atrial fl utter 
and ten had supra-ventricular tachycardia. Fetuses with hydrops were complicated 
of premature age delivery (p=0.025), lower birth weight (p=0.022) and required oral 
intubation (p=0.025). Amiodarone was used in forteen fetuses and was complicated 
with transient hypothyroidism (p=0.006). We report no neurological issues in our 
population. 47% presented post-natal arrhythmia. Patients with supra-ventricular 
tachycardia were still treated after one year (p=0.011). Post natal outcome is good 
with a majority of patients weaned off medication after one year even if we report 
three fetal deaths. Among the resistive tachycardias, we found three permanent 
junctional reciprocating tachycardias (including one requiring radiofrequency 
ablation at adult age) and one junctional ectopic tachycardia. 
Conclusion: Mortality rate is low in patients with fetal tachycardia, even though 
the incidence of post-natal arrhythmia is high. The need of cesarean should be 
discussed for well-tolerated tachycardias. Patients with hydrops are associated with 
a poor prognosis and still represent a challenge to treat. 
the septal band, inlet. The specimens were classifi ed according to the anatomic and 
clinical classifi cation of CHD (ACC-CHD).
Results: 67% of hearts had a VS D:
•  constant, of a single type, in tetralogy of Fallot and variants and common arterial 
trunk (outlet), in complete atrioventricular canal (CAVC, inlet), and in double 
inlet left ventricle (DILV, muscular). 
•  not constant with a predominant type, in 96% of double discordance (DD,inlet 
82%), 62% of heterotaxy syndromes (Hetx, inlet 93%), 93% of interrupted aortic 
arch (outlet 80%), 87% of double outlet right ventricle (outlet 77%). 
•  not constant, of variable type, in 68% of aortic coarctation (CoA: outlet 44%, 
membranous 35%, muscular 21%), 54% of transposition of the great arteries 
(TGA: outlet 40%, membranous 25%, muscular 25%, inlet 10%). 
•  rare, in anomalies of pulmonary veins (5%), Ebstein (14%), double inlet right 
ventricle (10%), coronary anomalies (25%).
•  isolated in 10% of all VS D: outlet 44%, membranous 36%, muscular 18%, inlet 2%.
• Major associations according to VS D type: 
• outlet: 60% “conotruncal” defects (CTD), 10% TGA
• inlet: 57% CAVC, 13% DD, 10% Hetx
• muscular: 33% DILV, 26% TGA, 13% isolated
• membranous: 30% TGA, 28% isolated, 16% CoA.
Conclusion: The VS D is an integral part of the phenotype in some CHD. In CoA 
and TGA the VS D is not constant and its anatomic distribution is similar to that in 
isolated VS D, indicating a likely random association. This reinforces the hypothesis 
of different genetic mechanisms in TGA and CTD. This original approach, using the 
anatomic characteristics of one part of the phenotype, could provide new insights in 
the grouping and aetiology of CHD.
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Background: Eisenmenger syndrome (ES) is the most advanced form of pulmonary 
arterial hypertension (PAH) related to congenital heart disease. Several studies have 
suggested that the location of the shunt causes differences in natural course and 
circulatory physiology between patients with ES. We therefore aimed to compare 
echocardiographic parameters and clinical variables in various types of ES. 
Methods and Results: In this longitudinal cohort study, 186 patients with ES 
and non-complex congenital heart disease were recruited, 34 with pre-tricuspid and 
152 with post-tricuspid shunt (75 ventricular septal defect (VS D), 57 complete atrio-
ventricular septal defect (AVS D), 16 patent ductusarteriosus (PDA), 3 truncusarteriosus, 
1aorto-pulmonary window). Patients with post-tricuspid shunts were younger in our 
cohort (p<0.001), they had higher BNP concentrations and reduced exercise tolerance 
compared to patients with post-tricuspid shunts. Right ventricular (RV) function was 
impaired in patients with ASD with larger right ventricles, impaired systolic function 
and adaptation. Pre-tricuspid defects patients also exhibit larger atria and raised right 
atrial pressure. Overall, the left ventricular eccentricity index was signifi cantly raised 
in ASD patients compared to others. Within post-tricuspid shunts, patients with AVS 
D had improved right ventricular function, whereas patients with PDA had decreased 
RV function.
Conclusion: Cardiac physiology and chronic adaptation in ES differ widely 
according to the location of the defect. Differences in RV function and adaptation are 
important between patients with pre- or post-tricuspid shunts and should be incorporated 
in the interpretation of echocardiography in ES.The improved RV function likely 
accounts for the prolonged course of PAH in patients with post-tricuspid shunt in the 
setting of ES compared to patients with ASD or other types of PAH.
